Aubagio-denopsy (7 mg, 14 mg)

Sanofi Aventis

“Aubagio” contains Drug / Molecule called Teriflunomide”. Aubagio is the active metabolite of the parent drug, leflunomide, which is use in the treatment of rheumatoid arthritis (RA). Leflunomide is rapidly converted almost entirely into Aubagio following oral ingestion and thus Aubagio has become the focus of development for use in patients with Multiple sclerosis.

Indication

Augagio is used in the treatment of Multiple sclerosis.

Note

Precaution

  • Aubagio is a prescription drug and should be used under proper medical guidance and advice.